NCT05323916 Comprehensive Intensive Stroke Rehabilitation
| NCT ID | NCT05323916 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charles University, Czech Republic |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2022-05-01 |
| Primary Completion | 2025-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2022-05-01 with a primary completion date of 2025-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, the investigators aim to assess the effectiveness of the Comprehensive Intensive Rehabilitation Program After Stroke implementing the International Classification of Functioning, Disability and Health model, and to compare it with two cohorts receiving Comprehensive Intensive Rehabilitation Program After Stroke of the same length but different in physical therapy content (program implementing modern technological approach and neuroproprioceptive "facilitation and inhibition"). Moreover, control group will undergo standard care.
Eligibility Criteria
Inclusion Criteria: * adults * after first ischemic stroke * early sub-acute phase * slight to moderately severe disability \[2 - 4 on the Modified Rankin Scale\] * 0 - 2 on the Pre-Stroke Modified Rankin Score * potential to accept 4 hours of comprehensive rehabilitation per day and to profit from physiotherapy * minimal or moderate motor deficit of upper or lower extremities (on NIHSS Item 5 or 6 scores 1-3 points) * able to perform activities of daily living prior to stroke event (0 - 2 on the Pre-Stroke Modified Rankin Score) * Czech is participants' native language or its knowledge is at the level of the mother tongue Exclusion Criteria: * low level of consciousness (vegetative state and/or minimally conscious state); severe cognitive decline that would interfere with administration of the tests, premorbid illiteracy, severe visual and/or auditory deficit that would prevent proper completion of the tests * behavioural disorders and/or lack of cooperation with therapist * severe medical problems with a poor prognosis, (e.g., severe frailty, advanced and incurable cancer, fracture, cardiovascular disorders as chronic heart failure NYHA III, IV, symptomatic coronary artery disease Angina Severity Class III, IV, respiratory insufficiency as chronic obstructive pulmonary disease GOLD IV, and other severe disease)
Contact & Investigator
Kamila Řasová, Dr.
PRINCIPAL INVESTIGATOR
Charles University, Czech Republic
Frequently Asked Questions
Who can join the NCT05323916 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05323916 currently recruiting?
Yes, NCT05323916 is actively recruiting participants. Contact the research team at kamila.rasova@gmail.com for enrollment information.
Where is the NCT05323916 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT05323916 clinical trial?
NCT05323916 is sponsored by Charles University, Czech Republic. The principal investigator is Kamila Řasová, Dr. at Charles University, Czech Republic. The trial plans to enroll 280 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.